均瑶健康：公司已前瞻性布局下一代领先菌株AKK菌相关研发

Group 1 - The company has proactively laid out the research and development of the next-generation leading strain AKK, which has a solid scientific foundation globally [1] - The AKK strain, particularly AKK WST01, has received patent authorization in 13 countries and has passed the US Self-GRAS certification [1] - The company has made significant progress from technological research and development to industrial process breakthroughs, becoming one of the few domestic enterprises capable of large-scale production of this strain [1]